Article
A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.
American journal of hematology - 1 Nov 2017
Sahoo Rupam, Ghosh Pamela, Chorev Michael, Halperin Jose A
Abstract excerpt
Clinical and experimental evidences support a link between the complement system and the pathogenesis of diabetes complications. CD59, an extracellular cell membrane-anchored protein, inhibits formation of the membrane attack complex (MAC), the main effector of complement-mediated tissue damage. This complement regulatory activity of human CD59 (hCD59) is inhibited by hyperglycemia-induced ɛ-amino glycation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
